The RIPK4 gene gives cells instructions that help the skin, face, hands, feet, and other tissues form properly before birth. If this gene does not work well, a baby may be born with changes in skin growth and in the development of the mouth, face, fingers, toes, or genital area. This gene plays an important role in helping skin cells mature and build a protective outer barrier. Pathogenic variants in the RIPK4 gene are linked to rare inherited conditions, including forms of popliteal pterygium syndrome and related developmental conditions.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for making proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. As a group, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can visit the LearnHub.
Overview
RIPK4Gene function
What if the gene works
The RIPK4 gene helps skin cells mature and form a strong protective surface. It also supports normal development of the skin, mouth, and limbs before birth.
Risk
What if the gene does not work
Variants in the RIPK4 gene can disrupt early skin, face, mouth, and limb development. Milder to more severe variants may cause features ranging from CHAND syndrome to popliteal pterygium syndromes, with cleft lip or palate, webbing, and severe limb changes.
Treatment
What does that mean for your treatment
No RIPK4-specific treatment or management approach is currently established, and pathogenic or loss-of-function variants in the RIPK4 gene do not currently guide any standard drug choice. The RIPK4 gene is being studied as a possible biomarker and treatment target in some cancers.
Conditions associated with RIPK4
Gene function
What if the gene works
Your skin and other body surfaces need cells to mature in the right order. The RIPK4 gene helps guide that process, especially in tissues that form protective outer layers. RIPK4 gene function is most closely linked to skin development and the building of a healthy skin barrier.
Inside surface cells, the RIPK4 gene makes a kinase (a protein that switches other proteins on). This helps pass along the messages that tell cells when to begin maturing.
The RIPK4 gene helps young skin cells develop into mature cells suited for the body’s surface. It supports the changes in cell activity that let these cells take on their final role.
RIPK4 helps skin and similar tissues build orderly layers instead of a loose sheet of cells. This organized stacking is part of normal skin development and ongoing renewal.
As surface cells mature, RIPK4 supports the production of proteins that strengthen the outer covering. This helps the skin form a barrier that holds in moisture and blocks everyday irritants.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not produce any noticeable effect and are part of natural genetic variation. In some instances, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RIPK4 gene can weaken or abolish the protein’s kinase activity, change its shape, or make it break down too soon, disrupting pathways used by surface cells as they mature. This is how RIPK4 gene variants affect protein function at a cellular level. Some variants leave partial activity, while more disruptive variants remove most function and are often linked to earlier or more extensive features in RIPK4-related conditions.
How variants are linked to conditions
Pathogenic variants in the RIPK4 gene are linked to rare inherited conditions, mainly Bartsocas-Papas syndrome and the related CHAND syndrome. These conditions can involve cleft lip or palate, webbing of the skin, changes in the eyes, hair, or nails, and differences in genital development. A RIPK4 gene variant linked to Bartsocas-Papas syndrome can confirm that diagnosis when the clinical features fit.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RIPK4, risk is mainly shaped by inherited gene changes rather than lifestyle or environmental factors. If both biological parents carry a harmful RIPK4 variant, the chance of having a child with a related condition is higher; anyone concerned about family risk should speak with a doctor or genetic counselor.
Inheritance of RIPK4 variants
RIPK4-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one RIPK4 gene variant from each parent, and the parents are typically healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of producing a carrier, and a 25% chance of neither. This RIPK4 inheritance pattern applies to the well-established conditions linked to this gene.
What does my RIPK4 result mean for my family?
For families with a disease-causing RIPK4 result, the condition is typically passed down in a recessive way. This usually means parents can carry the gene change without having symptoms, while brothers, sisters, or future children may also be carriers or, in some families, be affected. Close relatives may want to learn whether the same gene change runs in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the RIPK4 gene, clinicians use genetic testing for RIPK4 variants on a blood or saliva sample. The lab reads the gene's DNA sequence to look for changes and compares them with known variants. Results may confirm a diagnosis in the clinical setting or show that no relevant variant was found.
When should I consider getting a genetic test?
Genetic testing for the RIPK4 gene may be considered when a baby or fetus has a pattern of birth differences that can fit rare conditions linked to this gene, such as cleft lip or palate, skin webbing, or hand, foot, or genital differences. It may help when there is a family history of these conditions or a previous affected pregnancy.
A genetic result is only one part of your health story
Genetic findings can provide useful information, but how much they reveal varies by the condition and the kind of variant present. Factors such as lifestyle, environment, age, and medical history also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body handles some medicines, so the same treatment may work differently from one person to another. Small differences in genes can affect how a drug is broken down, how strongly it acts on its target, or how sensitive someone is to side effects. This kind of variation is common and is one reason a medicine may help a lot in one person but less in another. It can also shape how closely a treatment needs to be monitored during use.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies links between genes and medications to help explain why the same treatment can work differently in different people. With many drugs, genes influence how much effect a medicine has or how the body breaks it down. Understanding this can support treatment decisions that are both better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the RIPK4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices or predicting medication side effects, so any concerns about symptoms, treatments, or how medicines may affect you are best discussed with your doctor.
History
RIPK4 was identified in the late 1990s during studies of cell signaling proteins involved in skin development. It was first described under the name PKK, and later research connected it more clearly to inherited conditions affecting facial, limb, and skin formation. In recent decades, awareness of this gene’s role has grown as families with rare developmental conditions helped clarify its medical importance. From these first observations, research expanded steadily, linking changes in the RIPK4 gene to syndromes such as Bartsocas Papas syndrome and some forms of popliteal pterygium syndrome. These discoveries helped move RIPK4 from a laboratory finding to a gene with recognized importance in clinical genetics.